The economics of mild cognitive impairment

Alzheimer's and Dementia

Volumn 9, Issue 1, 2013, Pages 58-62

  Lin, Pei Jung ^a   Neumann, Peter J ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; Cost analysis; Cost effectiveness; Mild cognitive impairment

Indexed keywords

ALZHEIMER DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; ELECTRONIC MEDICAL RECORD; HEALTH CARE COST; HEALTH CARE POLICY; MILD COGNITIVE IMPAIRMENT; PATIENT CARE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; TREATMENT OUTCOME; WELLBEING;

EID: 84872111120     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2012.05.2117     Document Type: Note

References (51)

1. M.S. Albert, S.T. DeKosky, D. Dickson, B. Dubois, H.H. Feldman, and N.C. Fox The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement 7 2011 270 279
2. S. Gauthier, B. Reisberg, M. Zaudig, R.C. Petersen, K. Ritchie, and K. Broich Mild cognitive impairment Lancet 367 2006 1262 1270
3. A. Busse, A. Hensel, U. Guhne, M.C. Angermeyer, and S.G. Riedel-Heller Mild cognitive impairment: long-term course of four clinical subtypes Neurology 67 2006 2176 2185
4. B.L. Plassman, K.M. Langa, G.G. Fisher, S.G. Heeringa, D.R. Weir, and M.B. Ofstedal Prevalence of cognitive impairment without dementia in the United States Ann Intern Med 148 2008 427 434
5. J.J. Manly, M.X. Tang, N. Schupf, Y. Stern, J.P. Vonsattel, and R. Mayeux Frequency and course of mild cognitive impairment in a multiethnic community Ann Neurol 63 2008 494 506
6. O.L. Lopez, W.J. Jagust, S.T. DeKosky, J.T. Becker, A. Fitzpatrick, and C. Dulberg Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 1 Arch Neurol 60 2003 1385 1389
7. R.C. Petersen, G.E. Smith, S.C. Waring, R.J. Ivnik, E.G. Tangalos, and E. Kokmen Mild cognitive impairment: clinical characterization and outcome Arch Neurol 56 1999 303 308
8. M. Ganguli, H.H. Dodge, C. Shen, and S.T. DeKosky Mild cognitive impairment, amnestic type: an epidemiologic study Neurology 63 2004 115 121
9. F.A. Sloan, and D.H. Taylor Jr. Effect of Alzheimer disease on the cost of treating other diseases Alzheimer Dis Assoc Disord 16 2002 137 143
10. D.P. Rice, H.M. Fillit, W. Max, D.S. Knopman, J.R. Lloyd, and S. Duttagupta Prevalence, costs, and treatment of Alzheimer's disease and related dementia: a managed care perspective Am J Manag Care 7 2001 809 818
11. Bynum JP. Contract Report Prepared for the Alzheimer's Association. Characteristics, Costs and Health Service Use for Medicare Beneficiaries with a Dementia Diagnosis: Report 1: Medicare Current Beneficiary Survey. Chicago: Alzheimer's Association; 2009.
12. E.M. Gutterman, J.S. Markowitz, B. Lewis, and H. Fillit Cost of Alzheimer's disease and related dementia in managed-Medicare J Am Geriatr Soc 47 1999 1065 1071
13. J.W. Hill, R. Futterman, S. Duttagupta, V. Mastey, J.R. Lloyd, and H. Fillit Alzheimer's disease and related dementias increase costs of comorbidities in managed Medicare Neurology 58 2002 62 70
14. M. Weiner, N.R. Powe, W.E. Weller, T.J. Shaffer, and G.F. Anderson Alzheimer's disease under managed care: implications from Medicare utilization and expenditure patterns J Am Geriatr Soc 46 1998 762 770
15. T.C. Kuo, Y. Zhao, S. Weir, M.S. Kramer, and A.S. Ash Implications of comorbidity on costs for patients with Alzheimer disease Med Care 46 2008 839 846
16. P.J. Lin, D.I. Kaufer, M.L. Maciejewski, R. Ganguly, J.E. Paul, and A.K. Biddle An examination of Alzheimer's disease case definitions using Medicare claims and survey data Alzheimers Dement 6 2010 334 341
17. Alzheimer's Association 2012 Alzheimer's disease facts and figures Alzheimers Dement 8 2012 131 168
18. L. Jonsson, P. Lindgren, A. Wimo, B. Jonsson, and B. Winblad Costs of Mini Mental State Examination-related cognitive impairment Pharmacoeconomics 16 1999 409 416
19. J. Hill, H. Fillit, S.K. Thomas, and S. Chang Functional impairment, healthcare costs and the prevalence of institutionalisation in patients with Alzheimer's disease and other dementias Pharmacoeconomics 24 2006 265 280
20. D.L. Murman, Q. Chen, M.C. Powell, S.B. Kuo, C.J. Bradley, and C.C. Colenda The incremental direct costs associated with behavioral symptoms in AD Neurology 59 2002 1721 1729
21. M. Luppa, S. Heinrich, H. Matschinger, A. Hensel, T. Luck, and S.G. Riedel-Heller Direct costs associated with mild cognitive impairment in primary care Int J Geriatr Psychiatry 23 2008 963 971
22. S.M. Albert, S. Glied, H. Andrews, Y. Stern, and R. Mayeux Primary care expenditures before the onset of Alzheimer's disease Neurology 59 2002 573 578
23. E.D. Eaker, S.F. Mickel, P.H. Chyou, N.J. Mueller-Rizner, and J.P. Slusser Alzheimer's disease or other dementia and medical care utilization Ann Epidemiol 12 2002 39 45
24. A. Wimo, and B. Winblad Pharmacoeconomics of mild cognitive impairment Acta Neurol Scand Suppl 179 2003 94 99
25. P.M. McMahon, S.S. Araki, E.A. Sandberg, P.J. Neumann, and G.S. Gazelle Cost-effectiveness of PET in the diagnosis of Alzheimer disease Radiology 228 2003 515 522
26. P.M. McMahon, S.S. Araki, P.J. Neumann, G.J. Harris, and G.S. Gazelle Cost-effectiveness of functional imaging tests in the diagnosis of Alzheimer disease Radiology 217 2000 58 68
27. D. Getsios, S. Blume, K.J. Ishak, G. Maclaine, and L. Hernandez An economic evaluation of early assessment for Alzheimer's disease in the United Kingdom Alzheimers Dement 8 2012 22 30
28. D.L. Weimer, and M.A. Sager Early identification and treatment of Alzheimer's disease: social and fiscal outcomes Alzheimers Dement 5 2009 215 226
29. R.G. Stern, R.C. Mohs, M. Davidson, J. Schmeidler, J. Silverman, and E. Kramer-Ginsberg A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration Am J Psychiatry 151 1994 390 396
30. J.C. Morris, S. Edland, C. Clark, D. Galasko, E. Koss, and R. Mohs The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease Neurology 43 1993 2457 2465
31. R.C. Petersen Conversion Neurology 67 2006 S12 S13
32. B. Vellas, S. Andrieu, C. Sampaio, N. Coley, and G. Wilcock Endpoints for trials in Alzheimer's disease: a European task force consensus Lancet Neurol 7 2008 436 450
33. J.S. Roberts, J.H. Karlawish, W.R. Uhlmann, R.C. Petersen, and R.C. Green Mild cognitive impairment in clinical care: a survey of American Academy of Neurology members Neurology 75 2010 425 431
34. M. Storandt, E.A. Grant, J.P. Miller, and J.C. Morris Rates of progression in mild cognitive impairment and early Alzheimer's disease Neurology 59 2002 1034 1041
35. R.C. Petersen, P.S. Aisen, L.A. Beckett, M.C. Donohue, A.C. Gamst, and D.J. Harvey Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization Neurology 74 2010 201 209
36. S.M. Landau, D. Harvey, C.M. Madison, E.M. Reiman, N.L. Foster, and P.S. Aisen Comparing predictors of conversion and decline in mild cognitive impairment Neurology 75 2010 230 238
37. D.P. Devanand, X. Liu, M.H. Tabert, G. Pradhaban, K. Cuasay, and K. Bell Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer's disease Biol Psychiatry 64 2008 871 879
38. R.A. Sperling, P.S. Aisen, L.A. Beckett, D.A. Bennett, S. Craft, and A.M. Fagan Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement 7 2011 280 292
39. M.J. Hux, B.J. O'Brien, M. Iskedjian, R. Goeree, M. Gagnon, and S. Gauthier Relation between severity of Alzheimer's disease and costs of caring CMAJ 159 1998 457 465
40. N. Herrmann, D.Y. Tam, R. Balshaw, R. Sambrook, N. Lesnikova, and K.L. Lanctot The relation between disease severity and cost of caring for patients with Alzheimer disease in Canada Can J Psychiatry 55 2010 768 775
41. T. McLaughlin, H. Feldman, H. Fillit, M. Sano, F. Schmitt, and P. Aisen Dependence as a unifying construct in defining Alzheimer's disease severity Alzheimers Dement 6 2010 482 493
42. C.W. Zhu, C. Leibman, T. McLaughlin, A.S. Zbrozek, N. Scarmeas, and M. Albert Patient dependence and longitudinal changes in costs of care in Alzheimer's disease Dement Geriatr Cogn Disord 26 2008 416 423
43. D. Gallagher, A. Ni Mhaolain, L. Crosby, D. Ryan, L. Lacey, and R.F. Coen Dependence and caregiver burden in Alzheimer's disease and mild cognitive impairment Am J Alzheimers Dis Other Demen 26 2011 110 114
44. J.M. Bruce, M. McQuiggan, V. Williams, H. Westervelt, and G. Tremont Burden among spousal and child caregivers of patients with mild cognitive impairment Dement Geriatr Cogn Disord 25 2008 385 390
45. L. Garand, M.A. Dew, L.R. Eazor, S.T. DeKosky, and C.F. Reynolds III Caregiving burden and psychiatric morbidity in spouses of persons with mild cognitive impairment Int J Geriatr Psychiatry 20 2005 512 522
46. Williams JW, Plassman BL, Burke J, Holsinger T, Benjamin S. Preventing Alzheimer's Disease and Cognitive Decline. Rockville, MD: Prepared by the Duke Evidence-based Practice Center under Contract No. HHSA 290-2007-10066-I. Evidence Report/Technology Assessment No. 193. AHRQ Publication No. 10-E005; 2010.
47. J.T. Cohen, and P.J. Neumann Decision analytic models for Alzheimer's disease: state of the art and future directions Alzheimers Dement 4 2008 212 222
48. R.C. Petersen, G.E. Smith, R.J. Ivnik, E.G. Tangalos, D.J. Schaid, and S.N. Thibodeau Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals JAMA 273 1995 1274 1278
49. H. Fillit, D.S. Geldmacher, R.T. Welter, K. Maslow, and M. Fraser Optimizing coding and reimbursement to improve management of Alzheimer's disease and related dementias J Am Geriatr Soc 50 2002 1871 1878
50. B.L. Plassman, K.M. Langa, G.G. Fisher, S.G. Heeringa, D.R. Weir, and M.B. Ofstedal Prevalence of dementia in the United States: the aging, demographics, and memory study Neuroepidemiology 29 2007 125 132
51. J.C. Morris, S. Weintraub, H.C. Chui, J. Cummings, C. Decarli, and S. Ferris The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers Alzheimer Dis Assoc Disord 20 2006 210 216